Alan Dunton W.'s most recent trade in CorMedix Inc was a trade of 30,453 Common Stock done . Disclosure was reported to the exchange on Jan. 26, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| CorMedix Inc | Alan W. Dunton | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Jan 2026 | 30,453 | 70,703 (0%) | 0% | 0 | Common Stock | |
| CorMedix Inc | Alan Dunton W. | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Dec 2025 | 20,000 | 0 | - | - | Stock Option (Right to Buy Common Stock) | |
| CorMedix Inc | W. Dunton Alan | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.03 per share. | 30 Dec 2025 | 20,000 | 60,250 (0%) | 0% | 4.0 | 80,600 | Common Stock |
| CorMedix Inc | W. Dunton Alan | Director | Sale of securities on an exchange or to another person at price $ 13.00 per share. | 30 Dec 2025 | 20,000 | 40,250 (0%) | 0% | 13 | 260,000 | Common Stock |
| CorMedix Inc | Alan W. Dunton | Director | Sale of securities on an exchange or to another person at price $ 13.13 per share. | 12 Sep 2025 | 10,000 | 40,250 (0%) | 0% | 13.1 | 131,300 | Common Stock |
| CorMedix Inc | Alan W. Dunton | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.55 per share. | 12 Sep 2025 | 10,000 | 50,250 (0%) | 0% | 3.6 | 35,500 | Common Stock |
| CorMedix Inc | Alan W. Dunton | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Sep 2025 | 10,000 | 20,000 | - | - | Stock Option (Right to Buy Common Stock) | |
| CorMedix Inc | Alan W. Dunton | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jan 2025 | 25,000 | 40,250 (0%) | 0% | 0 | Common Stock | |
| CorMedix Inc | Alan W. Dunton | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Mar 2024 | 30,000 | 30,000 | - | - | Stock Option (Right to Buy Common Stock) | |
| CorMedix Inc | Alan Dunton W. | Director | Purchase of securities on an exchange or from another person at price $ 3.45 per share. | 14 Dec 2023 | 3,000 | 12,250 (0%) | 0% | 3.5 | 10,350 | Common Stock |
| CorMedix Inc | W. Dunton Alan | Director | Purchase of securities on an exchange or from another person at price $ 3.30 per share. | 14 Dec 2023 | 3,000 | 15,250 (0%) | 0% | 3.3 | 9,900 | Common Stock |
| CorMedix Inc | Alan W. Dunton | Director | Purchase of securities on an exchange or from another person at price $ 4.33 per share. | 17 May 2023 | 3,000 | 9,250 (0%) | 0% | 4.3 | 12,980 | Common Stock |
| CorMedix Inc | Alan W. Dunton | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jan 2023 | 20,000 | 20,000 | - | - | Stock Option (Right to Buy Common Stock) | |
| CorMedix Inc | Alan W. Dunton | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Feb 2022 | 20,000 | 20,000 | - | - | Stock Option (Right to Buy Common Stock) |